201 related articles for article (PubMed ID: 37031468)
21. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
Ruepert L; Quartero AO; de Wit NJ; van der Heijden GJ; Rubin G; Muris JW
Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD003460. PubMed ID: 21833945
[TBL] [Abstract][Full Text] [Related]
22. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.
Brenner DM; Moeller MJ; Chey WD; Schoenfeld PS
Am J Gastroenterol; 2009 Apr; 104(4):1033-49; quiz 1050. PubMed ID: 19277023
[TBL] [Abstract][Full Text] [Related]
23. Biofeedback for treatment of irritable bowel syndrome.
Goldenberg JZ; Brignall M; Hamilton M; Beardsley J; Batson RD; Hawrelak J; Lichtenstein B; Johnston BC
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31713856
[TBL] [Abstract][Full Text] [Related]
24. Systematic review and meta-analysis: Efficacy of patented probiotic, VSL#3, in irritable bowel syndrome.
Connell M; Shin A; James-Stevenson T; Xu H; Imperiale TF; Herron J
Neurogastroenterol Motil; 2018 Dec; 30(12):e13427. PubMed ID: 30069978
[TBL] [Abstract][Full Text] [Related]
25. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review.
Pratt C; Campbell MD
Probiotics Antimicrob Proteins; 2020 Sep; 12(3):834-839. PubMed ID: 31741311
[TBL] [Abstract][Full Text] [Related]
26. Probiotics for the management of irritable bowel syndrome: a systematic review and three-level meta-analysis.
Chen M; Yuan L; Xie CR; Wang XY; Feng SJ; Xiao XY; Zheng H
Int J Surg; 2023 Nov; 109(11):3631-3647. PubMed ID: 37565634
[TBL] [Abstract][Full Text] [Related]
27. Acupuncture for treatment of irritable bowel syndrome.
Manheimer E; Cheng K; Wieland LS; Min LS; Shen X; Berman BM; Lao L
Cochrane Database Syst Rev; 2012 May; 5(5):CD005111. PubMed ID: 22592702
[TBL] [Abstract][Full Text] [Related]
28. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
Liu N; Li J; Wang Y; Zhang S
J Ethnopharmacol; 2023 Dec; 317():116672. PubMed ID: 37328079
[TBL] [Abstract][Full Text] [Related]
29. [A meta-analysis of probiotics for the treatment of irritable bowel syndrome].
Hu Y; Tao L; Lyu B
Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):445-51. PubMed ID: 26080826
[TBL] [Abstract][Full Text] [Related]
30. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V; Gschossmann J; Layer P
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.
Moayyedi P; Ford AC; Talley NJ; Cremonini F; Foxx-Orenstein AE; Brandt LJ; Quigley EM
Gut; 2010 Mar; 59(3):325-32. PubMed ID: 19091823
[TBL] [Abstract][Full Text] [Related]
33. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
Maev IV; Okhlobystina OZ; Khalif IL; Andreev DN
Ter Arkh; 2023 Feb; 95(1):38-51. PubMed ID: 37167114
[TBL] [Abstract][Full Text] [Related]
34. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study.
Sisson G; Ayis S; Sherwood RA; Bjarnason I
Aliment Pharmacol Ther; 2014 Jul; 40(1):51-62. PubMed ID: 24815298
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
Zhang WX; Shi LB; Zhou MS; Wu J; Shi HY
J Med Microbiol; 2023 Sep; 72(9):. PubMed ID: 37772692
[No Abstract] [Full Text] [Related]
36. Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
Wang M; Xie X; Zhao S; Ma X; Wang Z; Zhang Y
Front Immunol; 2023; 14():1136343. PubMed ID: 37275867
[TBL] [Abstract][Full Text] [Related]
37. British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).
McKenzie YA; Thompson J; Gulia P; Lomer MC;
J Hum Nutr Diet; 2016 Oct; 29(5):576-92. PubMed ID: 27265510
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.
Vázquez-Frias R; Consuelo-Sánchez A; Acosta-Rodríguez-Bueno CP; Blanco-Montero A; Robles DC; Cohen V; Márquez D; Perez M
Paediatr Drugs; 2023 Jan; 25(1):115-126. PubMed ID: 36380186
[TBL] [Abstract][Full Text] [Related]
39.
Martoni CJ; Srivastava S; Leyer GJ
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
[TBL] [Abstract][Full Text] [Related]
40. Comparing probiotic and drug interventions in irritable bowel syndrome: a meta-analysis of randomised controlled trials.
van der Geest AM; Schukking I; Brummer RJM; van de Burgwal LHM; Larsen OFA
Benef Microbes; 2022 Aug; 13(3):183-194. PubMed ID: 35848115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
